John D Clements Selected Research

John D Clements Research Topics

Disease

15	Infections 01/2022 - 03/2003
6	Diarrhea 01/2020 - 01/2002
4	Plague (Bubonic Plague) 11/2007 - 03/2005
3	Vaccinia 01/2022 - 01/2019
3	Pneumonia (Pneumonitis) 01/2019 - 06/2010
3	Cholera 02/2014 - 01/2010
3	Alzheimer Disease (Alzheimer's Disease) 10/2003 - 11/2002
2	Viremia 12/2020 - 04/2006
2	Otitis Media 08/2015 - 07/2013
2	Poliomyelitis (Polio) 04/2015 - 01/2014
2	Malaria 01/2012 - 01/2005
2	Inflammation (Inflammations) 11/2011 - 01/2009
2	Human Influenza (Influenza) 03/2010 - 05/2009
2	Acquired Immunodeficiency Syndrome (AIDS) 11/2006 - 04/2006
1	Disease Progression 12/2020
1	Cytokine Release Syndrome 01/2019
1	Coinfection 06/2017
1	Bacillary Dysentery (Shigellosis) 06/2013
1	Hepatitis B 04/2012
1	Communicable Diseases (Infectious Diseases) 01/2012
1	Neoplasms (Cancer) 01/2012
1	Tuberculosis (Tuberculoses) 01/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2011
1	Crohn Disease (Crohn's Disease) 11/2011
1	Pneumococcal Infections 06/2010
1	Weight Loss (Weight Reduction) 03/2010
1	Experimental Arthritis 01/2009
1	Rheumatoid Arthritis 01/2009
1	Anthrax 06/2007
1	Periodontal Diseases (Periodontal Disease) 09/2005
1	Alveolar Bone Loss 10/2003
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2003

Drug/Important Bio-Agent (IBA)

27	VaccinesIBA 01/2022 - 03/2003
12	AntigensIBA 01/2015 - 03/2005
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2002
4	Enterotoxins (Enterotoxin)IBA 01/2019 - 01/2010
3	Immunoglobulin G (IgG)IBA 01/2022 - 08/2005
2	E coli heat-labile enterotoxinIBA 12/2020 - 01/2002
2	heat stable toxin (E coli)IBA 01/2020 - 03/2011
2	Neutralizing AntibodiesIBA 01/2019 - 01/2014
2	AntibodiesIBA 01/2019 - 01/2014
2	Immunoglobulin A (IgA)IBA 01/2014 - 04/2010
2	Type III Secretion SystemsIBA 06/2013 - 03/2012
2	CytokinesIBA 08/2012 - 12/2007
2	Amyloid beta-PeptidesIBA 10/2003 - 05/2003
2	VX (EDIM)IBA 03/2002 - 01/2002
1	GP 140IBA 12/2020
1	DNA (Deoxyribonucleic Acid)IBA 12/2020
1	Adenosine Diphosphate (ADP)IBA 01/2019
1	blinatumomabIBA 01/2019
1	Integration Host FactorsIBA 06/2017
1	Oral Poliovirus Vaccine (Sabin Vaccine)IBA 04/2015
1	Inactivated Poliovirus Vaccine (Salk Vaccine)FDA Link 04/2015
1	Polysaccharides (Glycans)IBA 02/2014
1	O Antigens (O Antigen)IBA 02/2014
1	Conjugate VaccinesIBA 02/2014
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 02/2014
1	EnzymesIBA 01/2014
1	ImmunosorbentsIBA 01/2014
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2013
1	Cholera Vaccines FDA Link 08/2012
1	Viral AntigensIBA 01/2012
1	EpitopesIBA 01/2012
1	Verapamil (Calan)FDA LinkGeneric 11/2011
1	Calcium Channels (Calcium Channel)IBA 11/2011
1	Ethanol (Ethyl Alcohol)IBA 06/2010
1	SolutionsIBA 06/2010
1	Cholera ToxinIBA 06/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2010
1	Immunologic Factors (Immunomodulators)IBA 03/2010
1	UreaseIBA 02/2010
1	Pravastatin (Pravachol)FDA LinkGeneric 01/2009
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2009
1	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 01/2009
1	CPG-oligonucleotideIBA 11/2007
1	aluminum sulfate (alum)IBA 11/2007
1	ISCOMsIBA 11/2006
1	Indicators and Reagents (Reagents)IBA 04/2006
1	Immunoglobulins (Immunoglobulin)IBA 08/2005
1	Membrane Transport Proteins (Biological Pump)IBA 01/2005
1	Virulence Factors (Pathogenicity Factors)IBA 10/2003
1	Peptides (Polypeptides)IBA 10/2003
1	Hemagglutinins (Hemagglutinin)IBA 10/2003

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 01/2019 - 02/2010
1	Immunomodulation 03/2010
1	Immunotherapy 11/2002